These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23574853)
1. Optimal timing of systemic therapy in resectable colorectal liver metastases. Ihemelandu C; Levine EA; Aklilu M; Yacoub G; Howerton R; Bolemon B; Graham M; Russell G; Shen P Am Surg; 2013 Apr; 79(4):414-21. PubMed ID: 23574853 [TBL] [Abstract][Full Text] [Related]
2. Multicentre study of perioperative Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062 [TBL] [Abstract][Full Text] [Related]
4. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC). Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397 [TBL] [Abstract][Full Text] [Related]
6. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865 [TBL] [Abstract][Full Text] [Related]
7. Posthepatectomy but not prehepatectomy chemotherapy was associated with a longer time to recurrence in patients with resectable colorectal liver metastases: Inverse probability of treatment weighting analysis. Yoshizaki Y; Kawaguchi Y; Seki Y; Sasaki S; Ichida A; Akamatsu N; Kaneko J; Arita J; Hasegawa K J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1006-1014. PubMed ID: 36740970 [TBL] [Abstract][Full Text] [Related]
8. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6). Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ; BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318 [TBL] [Abstract][Full Text] [Related]
9. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases. Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681 [TBL] [Abstract][Full Text] [Related]
10. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ; Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480 [TBL] [Abstract][Full Text] [Related]
11. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS]. Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159 [TBL] [Abstract][Full Text] [Related]
12. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Brouquet A; Overman MJ; Kopetz S; Maru DM; Loyer EM; Andreou A; Cooper A; Curley SA; Garrett CR; Abdalla EK; Vauthey JN Cancer; 2011 Oct; 117(19):4484-92. PubMed ID: 21446046 [TBL] [Abstract][Full Text] [Related]
13. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104 [TBL] [Abstract][Full Text] [Related]
14. Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer. Julio C; Benoist S; Allard MA; Navarro F; Pessaux P; Sa Cunha A; Brouquet A; J Surg Oncol; 2022 Aug; 126(2):330-338. PubMed ID: 35397122 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases. Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205 [TBL] [Abstract][Full Text] [Related]
16. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318 [TBL] [Abstract][Full Text] [Related]
18. Predictive Factors for the Survival Outcomes of Preoperative Chemotherapy in Patients with Resectable and Borderline Resectable Colorectal Cancer with Liver Metastasis. Inworn N; Senavat P; Aleenajitpong N; Chingchaimaneesri M; Siripoon T; Srirattanapong S; Suragul W; Ngamphaiboon N Asian Pac J Cancer Prev; 2023 Sep; 24(9):3037-3047. PubMed ID: 37774055 [TBL] [Abstract][Full Text] [Related]